Lanreotide Autogel in the Treatment of Symptomatic Polycystic Liver Disease (LOCKCYST)
This study has been completed.
Universitaire Ziekenhuizen Leuven
Information provided by (Responsible Party):
Dr Frederik Temmerman, Universitaire Ziekenhuizen Leuven
First received: January 11, 2011
Last updated: July 7, 2014
Last verified: July 2014
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||July 2014|
|Primary Completion Date:||July 2014 (Final data collection date for primary outcome measure)|
van Keimpema L, Nevens F, Vanslembrouck R, van Oijen MG, Hoffmann AL, Dekker HM, de Man RA, Drenth JP. Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial. Gastroenterology. 2009 Nov;137(5):1661-8.e1-2. doi: 10.1053/j.gastro.2009.07.052. Epub 2009 Jul 29.